JP2006527775A5 - - Google Patents

Download PDF

Info

Publication number
JP2006527775A5
JP2006527775A5 JP2006517257A JP2006517257A JP2006527775A5 JP 2006527775 A5 JP2006527775 A5 JP 2006527775A5 JP 2006517257 A JP2006517257 A JP 2006517257A JP 2006517257 A JP2006517257 A JP 2006517257A JP 2006527775 A5 JP2006527775 A5 JP 2006527775A5
Authority
JP
Japan
Prior art keywords
compound
alkyl
optionally
aryl
halo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006517257A
Other languages
English (en)
Japanese (ja)
Other versions
JP4889487B2 (ja
JP2006527775A (ja
Filing date
Publication date
Priority claimed from US10/462,507 external-priority patent/US6992090B2/en
Application filed filed Critical
Publication of JP2006527775A publication Critical patent/JP2006527775A/ja
Publication of JP2006527775A5 publication Critical patent/JP2006527775A5/ja
Application granted granted Critical
Publication of JP4889487B2 publication Critical patent/JP4889487B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006517257A 2003-06-16 2004-06-15 置換されたピペリジン化合物とその使用方法 Expired - Fee Related JP4889487B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/462,507 US6992090B2 (en) 2003-06-16 2003-06-16 Substituted piperidine compounds and methods of their use
US10/462,507 2003-06-16
PCT/US2004/018905 WO2004112704A2 (en) 2003-06-16 2004-06-15 Substituted piperidine compounds and methods of their use

Publications (3)

Publication Number Publication Date
JP2006527775A JP2006527775A (ja) 2006-12-07
JP2006527775A5 true JP2006527775A5 (cg-RX-API-DMAC7.html) 2011-12-01
JP4889487B2 JP4889487B2 (ja) 2012-03-07

Family

ID=33511484

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006517257A Expired - Fee Related JP4889487B2 (ja) 2003-06-16 2004-06-15 置換されたピペリジン化合物とその使用方法

Country Status (8)

Country Link
US (3) US6992090B2 (cg-RX-API-DMAC7.html)
EP (2) EP1638565A4 (cg-RX-API-DMAC7.html)
JP (1) JP4889487B2 (cg-RX-API-DMAC7.html)
CN (1) CN1826115B (cg-RX-API-DMAC7.html)
AU (1) AU2004249178B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0411585A (cg-RX-API-DMAC7.html)
CA (1) CA2529524A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004112704A2 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7381721B2 (en) 2003-03-17 2008-06-03 Adolor Corporation Substituted piperidine compounds
US6992090B2 (en) * 2003-06-16 2006-01-31 Adolor Corporation Substituted piperidine compounds and methods of their use
US8131026B2 (en) 2004-04-16 2012-03-06 Validity Sensors, Inc. Method and apparatus for fingerprint image reconstruction
DE602005022900D1 (de) 2004-10-04 2010-09-23 Validity Sensors Inc Fingerabdruckerfassende konstruktionen mit einem substrat
MY145633A (en) 2006-03-01 2012-03-15 Theravance Inc 8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
JP2010500372A (ja) * 2006-08-09 2010-01-07 スミスクライン ビーチャム コーポレーション オピオイド受容体に対するアンタゴニストまたはインバースアゴニストとしての新規化合物
TWI409067B (zh) 2007-02-28 2013-09-21 Theravance Inc 8-氮雜雙環〔3.2.1〕辛烷化合物之結晶型
CA2688570A1 (en) * 2007-05-31 2008-12-04 F.P.L. Pharma Inc. Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof
CA2696285A1 (en) 2007-08-15 2009-02-19 Schering Corporation Substituted bicyclic piperidinyl- and piperazinyl-sulfonamides useful to inhibit 11.beta.-hydroxysteroid dehydrogenase type-1
TWI423801B (zh) * 2007-08-27 2014-01-21 Theravance Inc 作為μ類鴉片受體拮抗劑之8-氮雜雙環〔3.2.1〕辛基-2-羥基苯甲醯胺化合物
US7947710B2 (en) 2007-08-27 2011-05-24 Theravance, Inc. Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
US7902221B2 (en) * 2007-08-27 2011-03-08 Theravance, Inc. Amidoalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
ES2465621T3 (es) * 2007-08-27 2014-06-06 Theravance, Inc. Compuestos de heteroarilalquil-8-azabiciclo[3.2.1]octano, como antagonistas de los receptores opiodes mu
CA2702680A1 (en) * 2007-10-18 2009-04-23 Aiko Biotechnology Combination analgesic employing opioid and neutral antagonist
US8748448B2 (en) 2007-10-18 2014-06-10 Aiko Biotechnology Combination analgesic employing opioid agonist and neutral antagonist
AU2009249069A1 (en) 2008-05-20 2009-11-26 Neurogesx, Inc. Carbonate prodrugs and methods of using the same
JP5757864B2 (ja) * 2008-05-20 2015-08-05 ニューロジェシックス, インコーポレイテッド 水溶性アセトアミノフェン類似体
US20100311782A1 (en) * 2009-06-08 2010-12-09 Adolor Corporation Substituted piperidinylpropanoic acid compounds and methods of their use
WO2011161646A2 (en) 2010-06-25 2011-12-29 Ranbaxy Laboratories Limited Process for the preparation of alvimopan or its pharmaceutically acceptable salt or solvate thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191771A (en) 1974-09-06 1980-03-04 Eli Lilly And Company Analgesic method using 1,3,4-trisubstituted-4-arylpiperidines
US4115400A (en) 1976-05-27 1978-09-19 Eli Lilly And Company 1-Azoniabicyclo[3.1.0]hexanes
US4176186A (en) 1978-07-28 1979-11-27 Boehringer Ingelheim Gmbh Quaternary derivatives of noroxymorphone which relieve intestinal immobility
MC1289A1 (fr) 1978-10-13 1980-07-22 Hoffmann La Roche Phenyl quinolizidines
US4931558A (en) 1983-09-21 1990-06-05 Eli Lilly And Company Processes for preparing intermediates of picenadol
US4891379A (en) 1987-04-16 1990-01-02 Kabushiki Kaisha Kobe Seikosho Piperidine opioid antagonists
GB8803076D0 (en) 1988-02-10 1988-03-09 Erba Carlo Spa 3'-deamino-4'-deoxy-4'-amino anthracyclines
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
US5250542A (en) 1991-03-29 1993-10-05 Eli Lilly And Company Peripherally selective piperidine carboxylate opioid antagonists
CZ284993B6 (cs) * 1991-03-29 1999-04-14 Eli Lilly And Company Derivát piperidinu
US5270328A (en) 1991-03-29 1993-12-14 Eli Lilly And Company Peripherally selective piperidine opioid antagonists
US5434171A (en) 1993-12-08 1995-07-18 Eli Lilly And Company Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates
US5972954A (en) 1997-11-03 1999-10-26 Arch Development Corporation Use of methylnaltrexone and related compounds
JP4498602B2 (ja) 1998-03-10 2010-07-07 リサーチ・トライアングル・インスティチュート 新規なオピエート化合物、その調製法及び使用法
US6900228B1 (en) 1998-03-10 2005-05-31 Research Triangle Institute Opiate compounds, methods of making and methods of use
GB9912411D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
US6451806B2 (en) * 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
AU4136901A (en) * 1999-11-29 2001-06-18 Adolor Corporation Novel methods for the treatment and prevention of dizziness and pruritus
EP1244447B1 (en) * 1999-11-29 2007-01-10 Adolor Corporation Novel methods and compositions involving opioids and antagonists thereof
EP1244448B1 (en) * 1999-11-29 2009-05-27 Adolor Corporation Novel methods for the treatment and prevention of ileus
US20030100562A1 (en) 1999-11-30 2003-05-29 Yudu Cheng Diketopiperazine derivatives to inhibit thrombin
EP1325912A4 (en) 2000-10-12 2004-05-12 Ssp Co Ltd 2,2-DIPHENYLBUTANAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
ATE292625T1 (de) 2000-10-31 2005-04-15 Rensselaer Polytech Inst 8-substituierte 2,6-methano-3-benzazocine und 3- substituierte morphinane als opioidrezeptorbindende agenzien
US6974824B2 (en) 2001-01-08 2005-12-13 Research Triangle Institute Kappa opioid receptor ligands
US6794510B2 (en) * 2002-08-08 2004-09-21 Adolor Corporation Processes for the preparation of peripheral opioid antagonist compounds and intermediates thereto
US7381721B2 (en) 2003-03-17 2008-06-03 Adolor Corporation Substituted piperidine compounds
US20040204453A1 (en) 2003-04-14 2004-10-14 Pfizer Inc 4-Phenyl-piperidine compounds and their use as modulators of opioid receptors
US6992090B2 (en) * 2003-06-16 2006-01-31 Adolor Corporation Substituted piperidine compounds and methods of their use

Similar Documents

Publication Publication Date Title
JP2003528819A5 (cg-RX-API-DMAC7.html)
US12582647B2 (en) Systems and methods for treating an opioid-induced adverse pharmacodynamic response
JP2005530798A5 (cg-RX-API-DMAC7.html)
ES2729679T3 (es) Derivados de morfinano para el tratamiento de la sobredosis de fármacos
RU2009125597A (ru) Пролекарства и способы их получения и применения
RU2005113996A (ru) Способы лечения боли введением антагониста фактора роста нервов и опиоидного анальгетика, и содержащие их композиции
JP2002506047A (ja) Nmdaレセプター拮抗薬及び麻酔性鎮痛薬を含む鎮痛組成物。
WO2020055725A4 (en) Dopamine d3 receptor selective antagonists/partial agonists and uses thereof
JP2003517476A5 (cg-RX-API-DMAC7.html)
JP2008534613A5 (cg-RX-API-DMAC7.html)
WO2009121018A4 (en) Opioid-nornicotine codrugs for pain management
US10226457B2 (en) Systems and methods for treating an opioid-induced adverse pharmacodynamic response
JP2005500373A5 (cg-RX-API-DMAC7.html)
RU2012124063A (ru) Лекарственная комбинация с теобромином и ее использование в лечении
EP1962589A2 (en) Synergistic combinations of norketamine and opioid analgesics
HUP0401013A2 (hu) Hatóanyag-kombináció nikotinfüggőség gyógyszeres kezelésére és ezt tartalmazó gyógyszerkészítmény
JP2011513278A5 (cg-RX-API-DMAC7.html)
JP2002526409A5 (cg-RX-API-DMAC7.html)